Table II.
Significant predictors of 1-year TVR among patients receiving BMS
| Parameters | Precatheterization model
|
Procedural model
|
||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| OR | 95% lower CI | 95% upper CI | χ2 | P | OR | 95% lower CI | 95% upper CI | χ2 | P | |
| Insulin-treated diabetes | 1.521 | 1.332 | 1.737 | 38.46 | <.001 | 1.441 | 1.261 | 1.647 | 28.80 | <.001 |
| Non–insulin-treated diabetes | 1.276 | 1.154 | 1.411 | 22.54 | <.001 | 1.240 | 1.120 | 1.373 | 17.22 | <.001 |
| Prior PCI | 1.250 | 1.136 | 1.375 | 21.02 | <.001 | 1.294 | 1.176 | 1.423 | 27.98 | <.001 |
| Presentation with NSTE ACS | 1.201 | 1.100 | 1.311 | 16.74 | <.001 | 1.181 | 1.081 | 1.290 | 13.69 | <.001 |
| Cerebrovascular disease | 1.210 | 1.089 | 1.344 | 12.57 | <.001 | 1.190 | 1.071 | 1.322 | 10.41 | .001 |
| Age (per 5 y) | 0.948 | 0.918 | 0.978 | 10.88 | <.001 | 0.935 | 0.905 | 0.965 | 16.68 | <.001 |
| Current CHF | 0.828 | 0.732 | 0.936 | 9.09 | .003 | 0.801 | 0.707 | 0.906 | 12.40 | <.001 |
| Prior CABG | 1.161 | 1.043 | 1.292 | 7.43 | .006 | |||||
| BMI per 5 units (when ≥30) | 0.919 | 0.863 | 0.979 | 6.90 | .009 | 0.908 | 0.847 | 0.972 | 7.59 | .006 |
| BMI per 5 units (when <30) | 1.097 | 1.020 | 1.179 | 6.26 | .012 | |||||
| 2-vessel PCI (vs single) | 1.511 | 1.345 | 1.698 | 62.03 | <.001 | |||||
| 3-vessel PCI (vs single) | 2.175 | 1.533 | 3.088 | |||||||
| LCx PCI (vs LAD) | 0.828 | 0.741 | 0.924 | 16.63 | <.001 | |||||
| LM PCI (vs LAD) | 0.959 | 0.719 | 1.279 | |||||||
| RCA PCI (vs LAD) | 0.834 | 0.753 | 0.924 | |||||||
| Minimum stent diameter (per mm) | 0.696 | 0.645 | 0.752 | 85.63 | <.001 | |||||
| Total stent length (per mm) | 1.005 | 1.003 | 1.007 | 29.95 | <.001 | |||||